Turkish Journal of Medical Sciences
Author ORCID Identifier
DİLEK URAL: 0000-0003-0224-1433
LALE DİNÇ ASARCIKLI: 0000-0002-7828-9487
İNCİ TUĞÇE ÇÖLLÜOĞLU: 0000-0002-2227-6177
ANIL ŞAHİN: 0000-0003-3416-5965
YÜKSEL ÇAVUŞOĞLU: 0000-0002-4027-9873
MEHMET YILMAZ: 0000-0002-8169-8628
SANEM NALBANTGİL: 0000-0002-9798-9796
NAİM ATA: 0000-0001-6947-2821
MUSTAFA ÜLGÜ: 0000-0003-0825-1851
ŞUAYİP BİRİNCİ: 0000-0001-8104-6198
SELDA MURAT: 0000-0002-3935-0222
EMRE DEMİR: 0000-0001-7552-8967
EMİNE KANIK: 0000-0002-7068-1599
AHMET ÇELİK: 0000-0002-9417-7610
DOI
10.55730/1300-0144.5932
Abstract
Background/aim:Final diagnosis of heart failure (HF) relies on a combination clinical findings, laboratory and imaging tests.The aim of this study was to review the diagnostic approach to HF in Turkiye.Materials and methods:This study is a subanalysis of the nationwide TRends-HF study based on anonymized data of National Electronic Database between January 1, 2016, and December 31, 2022.Variables including date of birth, sex, socioeconomic development index, place of initial HF diagnosis, comorbidities, investigations, and diagnostic procedures were reported.Laboratory variables, including complete blood count, natriuretic peptides (NP), estimated glomerular filtration rate, uric acid, electrolytes, albumin, lipid profile, ferritin and hemoglobin A1c levels and other imaging techniques (coronary angiogram [CAG], transthoracic echocardiography [TTE], chest X-ray [CXR] etc.) during initial diagnosis and/or follow-up of HF patients were obtained from the National Electronic Database.The diagnostic test usage rates were analyzed according to years, geographical regions, socioeconomic regions of Turkiye.Results:The study population consisted of 2.722.151 HF patients (51.7% female, mean age 68.33±14.01 years).All HF patients had at least one electrocardiogram and one TTE examination and all had routine biochemical tests at any time during the follow-up period.CXR utilization rate was 93.7%, while CAG utilization rate was 17.9%.Coronary computed tomographic angiography and cardiac magnetic resonance imaging were performed in only 1.8% and 0.3%.Among all Turkish HF patients, 16.3% had at least one NP measurement.The highest rate of NP use was observed in Central Anatolia (21.0%) and the lowest rate in the Aegean Region (11.7%).NP measurement during HF diagnosis revealed a rising trend over time (12.3% in 2016 vs. 26.3% in 2021).Conclusion:The widespread use of TTE at the beginning of the diagnosis and during follow-up is important for providing quality care to HF patients in Turkiye.However, detailed laboratory tests and advanced imaging methods are not used enough,which could lead to problems in patient management.
Keywords
Heart failure, diagnostic tools, natriuretic peptides, nationwide study
First Page
1461
Last Page
1469
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
URAL, DİLEK; DİNÇ ASARCIKLI, LALE; ÇÖLLÜOĞLU, İNCİ TUĞÇE; ŞAHİN, ANIL; ÇAVUŞOĞLU, YÜKSEL; YILMAZ, MEHMET BİRHAN; NALBANTGİL, SANEM; ATA, NAİM; ÜLGÜ, MUSTAFA MAHİR; BİRİNCİ, ŞUAYİP; MURAT, SELDA; DEMİR, EMRE; KANIK, EMİNE ARZU; and ÇELİK, AHMET
(2024)
"Diagnostic approach to heart failure in Türkiye,"
Turkish Journal of Medical Sciences: Vol. 54:
No.
7, Article 7.
https://doi.org/10.55730/1300-0144.5932
Available at:
https://journals.tubitak.gov.tr/medical/vol54/iss7/7